The expression of TIM‐3 is often increased in infiltrating T cells in chronic HBV‐infected liver, and the TIM‐3/galectin‐9 pathway consistently predicts a poor prognosis in patients with HBV‐associated HCC.57 The gene discussed is HAVCR2; the disease is hepatocellular carcinoma.